Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 364

    1.

    Increased glucocorticoid receptor and 11{beta}-hydroxysteroid dehydrogenase type 1 expression in hepatocytes may contribute to the phenotype of type 2 diabetes in db/db mice.

    Liu Y, Nakagawa Y, Wang Y, Sakurai R, Tripathi PV, Lutfy K, Friedman TC.

    Diabetes. 2005 Jan;54(1):32-40.PMID: 15616008 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Liver X receptor agonist T0901317 inhibition of glucocorticoid receptor expression in hepatocytes may contribute to the amelioration of diabetic syndrome in db/db mice.

    Liu Y, Yan C, Wang Y, Nakagawa Y, Nerio N, Anghel A, Lutfy K, Friedman TC.

    Endocrinology. 2006 Nov;147(11):5061-8. Epub 2006 Jul 27.PMID: 16873540 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Reduction of hepatic glucocorticoid receptor and hexose-6-phosphate dehydrogenase expression ameliorates diet-induced obesity and insulin resistance in mice.

    Liu Y, Nakagawa Y, Wang Y, Liu L, Du H, Wang W, Ren X, Lutfy K, Friedman TC.

    J Mol Endocrinol. 2008 Aug;41(2):53-64. Epub 2008 Jun 4.PMID: 18524870 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Leptin activation of corticosterone production in hepatocytes may contribute to the reversal of obesity and hyperglycemia in leptin-deficient ob/ob mice.

    Liu Y, Nakagawa Y, Wang Y, Li R, Li X, Ohzeki T, Friedman TC.

    Diabetes. 2003 Jun;52(6):1409-16.PMID: 12765951 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    11beta-Hydroxysteroid dehydrogenase type 1 regulates insulin and glucagon secretion in pancreatic islets.

    Swali A, Walker EA, Lavery GG, Tomlinson JW, Stewart PM.

    Diabetologia. 2008 Nov;51(11):2003-11. Epub 2008 Sep 9.PMID: 18779947 [PubMed - indexed for MEDLINE]Related articles

    6.

    Regulation of 11beta-hydroxysteroid dehydrogenase type 1 and glucose-stimulated insulin secretion in pancreatic islets of Langerhans.

    Ortsäter H, Alberts P, Warpman U, Engblom LO, Abrahmsén L, Bergsten P.

    Diabetes Metab Res Rev. 2005 Jul-Aug;21(4):359-66.PMID: 15586384 [PubMed - indexed for MEDLINE]Related articles

    7.

    Is the metabolic syndrome an intracellular Cushing state? Effects of multiple humoral factors on the transcriptional activity of the hepatic glucocorticoid-activating enzyme (11beta-hydroxysteroid dehydrogenase type 1) gene.

    Iwasaki Y, Takayasu S, Nishiyama M, Tsugita M, Taguchi T, Asai M, Yoshida M, Kambayashi M, Hashimoto K.

    Mol Cell Endocrinol. 2008 Mar 26;285(1-2):10-8. Epub 2008 Feb 2.PMID: 18313835 [PubMed - indexed for MEDLINE]Related articles

    8.

    Glucocorticoid regulation of the promoter of 11beta-hydroxysteroid dehydrogenase type 1 is indirect and requires CCAAT/enhancer-binding protein-beta.

    Sai S, Esteves CL, Kelly V, Michailidou Z, Anderson K, Coll AP, Nakagawa Y, Ohzeki T, Seckl JR, Chapman KE.

    Mol Endocrinol. 2008 Sep;22(9):2049-60. Epub 2008 Jul 10.PMID: 18617597 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Insulin and dexamethasone dynamically regulate adipocyte 11beta-hydroxysteroid dehydrogenase type 1.

    Balachandran A, Guan H, Sellan M, van Uum S, Yang K.

    Endocrinology. 2008 Aug;149(8):4069-79. Epub 2008 May 8.PMID: 18467433 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Alteration of 11beta-hydroxysteroid dehydrogenase type 1 in skeletal muscle in a rat model of type 2 diabetes.

    Zhang M, Lv XY, Li J, Xu ZG, Chen L.

    Mol Cell Biochem. 2009 Apr;324(1-2):147-55. Epub 2009 Jan 1.PMID: 19118409 [PubMed - indexed for MEDLINE]Related articles

    11.

    11beta-Hydroxysteroid dehydrogenase Type 1: genetic polymorphisms are associated with Type 2 diabetes in Pima Indians independently of obesity and expression in adipocyte and muscle.

    Nair S, Lee YH, Lindsay RS, Walker BR, Tataranni PA, Bogardus C, Baier LJ, Permana PA.

    Diabetologia. 2004 Jun;47(6):1088-95. Epub 2004 May 20.PMID: 15156315 [PubMed - indexed for MEDLINE]Related articles

    12.

    Liver-selective transgene rescue of hypothalamic-pituitary-adrenal axis dysfunction in 11beta-hydroxysteroid dehydrogenase type 1-deficient mice.

    Paterson JM, Holmes MC, Kenyon CJ, Carter R, Mullins JJ, Seckl JR.

    Endocrinology. 2007 Mar;148(3):961-6. Epub 2006 Dec 14.PMID: 17170103 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    MRNA and enzyme activity of hepatic 11beta-hydroxysteroid dehydrogenase type 1 are elevated in C57BL/KsJ-db/db mice.

    Aoki K, Homma M, Hirano T, Oka K, Satoh S, Mukasa K, Ito S, Sekihara H.

    Life Sci. 2001 Oct 12;69(21):2543-9.PMID: 11693261 [PubMed - indexed for MEDLINE]Related articles

    15.

    Bezafibrate regulates the expression and enzyme activity of 11beta-hydroxysteroid dehydrogenase type 1 in murine adipose tissue and 3T3-L1 adipocytes.

    Nakano S, Inada Y, Masuzaki H, Tanaka T, Yasue S, Ishii T, Arai N, Ebihara K, Hosoda K, Maruyama K, Yamazaki Y, Shibata N, Nakao K.

    Am J Physiol Endocrinol Metab. 2007 Apr;292(4):E1213-22. Epub 2006 Dec 26.PMID: 17190905 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Localization and glucocorticoid regulation of 11beta-hydroxysteroid dehydrogenase type 1 mRNA in the male mouse forebrain.

    Pelletier G, Luu-The V, Li S, Bujold G, Labrie F.

    Neuroscience. 2007 Mar 2;145(1):110-5. Epub 2007 Jan 4.PMID: 17207581 [PubMed - indexed for MEDLINE]Related articles

    17.

    Increased glucocorticoid receptor expression in human skeletal muscle cells may contribute to the pathogenesis of the metabolic syndrome.

    Whorwood CB, Donovan SJ, Flanagan D, Phillips DI, Byrne CD.

    Diabetes. 2002 Apr;51(4):1066-75.PMID: 11916927 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    11beta-hydroxysteroid dehydrogenase type 1 and obesity.

    Morton NM, Seckl JR.

    Front Horm Res. 2008;36:146-64. Review.PMID: 18230901 [PubMed - indexed for MEDLINE]Related articles

    19.

    Retinoic acid reduces glucocorticoid sensitivity in C2C12 myotubes by decreasing 11beta-hydroxysteroid dehydrogenase type 1 and glucocorticoid receptor activities.

    Aubry EM, Odermatt A.

    Endocrinology. 2009 Jun;150(6):2700-8. Epub 2009 Jan 29.PMID: 19179438 [PubMed - indexed for MEDLINE]Related articles

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination

    Supplemental Content

    Find related data